General MedicationsORALStandard
ELUXADOLINE
ELUXADOLINE
Standard Dose
100MG
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Prescription
Summary
Approval overview ELUXADOLINE is listed in Drugs@FDA under application 213613 (ANDA).
Review priority: STANDARD Marketing status: Prescription Active ingredient ELUXADOLINE Form and strength TABLET; ORAL - 100MG Sponsor ASCEND LABORATORIES, LTD Submission history Latest submission status date: 2021-12-17 00:00:00.
Structured Monograph
Clinical summary
Approval overview ELUXADOLINE is listed in Drugs@FDA under application 213613 (ANDA). Review priority: STANDARD Marketing status: Prescription Active ingredient ELUXADOLINE Form and strength TABLET; ORAL - 100MG Sponsor ASCEND LABORATORIES, LTD Submission history Latest submission status date: 2021-12-17 00:00:00. Submission type: ORIG.
Monitoring
- • Marketing status: Prescription
- • Review priority: STANDARD
Interaction Notes
- No interaction notes stored yet.